Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.35p +3.33% 10.85p 10.50p 11.20p 10.85p 10.50p 10.50p 419,043 11:00:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -0.5 -0.2 - 22.00

Eden Research Share Discussion Threads

Showing 6851 to 6871 of 7400 messages
Chat Pages: Latest  284  283  282  281  280  279  278  277  276  275  274  273  Older
DateSubjectAuthorDiscuss
26/4/2019
15:05
The Italian local regulatory authorities have judged that "emergency" authorisations are needed in the local market in order to meet the requirements of growers in the absence of suitable commercially-available alternatives. The words "lack of suitable competition" and "open door" spring to mind for Cedroz take-up in Italy. The local regulatory authorities are obviously well informed regarding Cedroz.
weyweyumfozo
26/4/2019
14:58
Yes, indeed, Wan, and brings forward the likelihood of additional income stream for 2019!
brucie5
26/4/2019
14:51
Well, am I the only one to find today's RNS even vaguely exciting? Eastman is really working hard for us, it seems. They seem to have impressed the Italians, who have a huge agricultural sector; never mind the fact that Italy, as the world's largest wine producer is already using Mevalone via Sipcam.
brucie5
26/4/2019
14:43
Super, Your post above is right in that the statement you re-quote should not be underestimated. It is quite a statement and Eden should look to capitalise on the same. However,...… ipeesquint is right in my book about the jam tomorrow, inappropriate and disproportionate pay rises, bonuses and share options that have been awarded. This doesn't say 'we are in it together or our interests are aligned with yours' because they're simply not when the share price is 3 years static and illiquid. That really is a statement suggesting Cedroz is about to grab immediate and significant market share straight out the gate in Italy. Investors are right to be weary with Eden and they will look to exit as soon as. New investors are right to be wary of Eden until delivery changes. I love the Eden story, but I too am getting tired of it. I would love it again though if Eden would drive their share price to many multiples of today's price, today and then we can start to look forward to the forward journey again. The share price is the biggest elephant in the room. So I am all for the pay rises, bonuses and share options, with the former two coming when Eden's share price is north of 30p and the latter exercisable when the shares are 40-50p
investingisatrickygame
26/4/2019
14:28
Ipeesquint, The words of Zach Bush..Autism rates have doubled in the last 6 years to 1 in every 30 kids and by 2030/5 based on current projections 1 in 3 children will be diagnosed as being on the Autistic spectrum. 46% of children have a chronic Health issue. These are end of Empire numbers. @13min hTTps://www.youtube.com/watch?v=X3aOQ0N74PI&fbclid=IwAR08MulF_LQ5oC8iOFsSD_7Nl4F0arIVQVo0s7ewgRlHwardxQCFgnusiys With these sorts of stats routinely thrown around and bio technology rapidly evolving I think were all frustrated. That may well be down to management but I lean more towards NDA's and evolving product development as a reason why were still waiting. The statement we all read today, below, should not be underestimated imo as not only does it show a vacuum in the Green revolution technology, it marks a step change in the leverage our partners have and their confidence that the product performs better than conventional chemistry. It shows the confidence and trust regulators are gaining for Eden technology. It also marks the acceptance and maturity of Eden's tech reputation for Biopesticide products that was not their or was more cautious with Mevalone. As we have all grumbled about the slow progress of the share price the Times have changed before our eyes. The tide is turning in Eden's favour, but not many realise it right now.. but they will. 'Such emergency authorisations are allowed by EU member states when local regulatory authorities judge that they are needed in the local market in order to meet the requirements of growers in the absence of suitable commercially-available alternatives'.
supersonico
26/4/2019
13:56
Investing all true what your saying. I don’t post often as I am a bit weary of Eden having owned quite a pile for so long. I hope one day to get a bit of that future jam but suspect my kids are more likely to benefit when I am gone. It is my worst ever investment and while I still have hope .....it diminishes every time Sean awards an inappropriate and disproportionate pay rise to him and Alex. The AGM used to be an exciting time but of late I find myself bashing my teeth at what comes out of it. Groaning is also a firm favourite and a requirement for a long time holder of which there are surprisingly many. I’m not sure what keeps us here anymore. Good luck all.
ipeesquint
26/4/2019
12:03
Dave Goulson talks about the causes of insect declines, and how we might all help to reverse them (only the short intro is in German!): hTTps://www.youtube.com/watch?v=JZYWYK4GbAo&list=PLP4P7rl8GkSdcrwFOsvO4shVVxlERLXK0&index=5&t=0s …………….. hTTps://www.youtube.com/watch?time_continue=41&v=u_o7FNkjzb0
supersonico
26/4/2019
10:15
Le cognac Hennessy veut bannir les herbicides d’ici 2028 hTTp://www.terredevins.com/actualites/le-cognac-hennessy-veut-bannir-les-herbicides-dici-2028/ The Hennessy cognac house intends to ban herbicides vines of its 1,600 winemakers partners by 2028 by proposing a technical and financial support plan, we learned Thursday from the world number one. The CEO of the group, Bernard Peillon, made this announcement Wednesday night, during the meeting partners in Cognac, with independent winemakers who exploit 32,000 hectares on behalf of Hennessy on a total of 76,000 ha for the appellation in Charente and Charente -Maritime, according to its communication department. According to the calendar unveiled at this annual meeting, winemakers delivering to Hennessy will have to engage in an environmental certification process within three years and obtain in 2025 the "High environmental value" (HVE) label, which imposes the need to protect the environment. plant and animal biodiversity and limited treatments. In nine years, Hennessy's partner vineyards will no longer need to use any herbicide. To get rid of glyphosate, flazasulfuron and other weed killers, Hennessy, which belongs to the luxury giant LVMH, has carried out conclusive tests on its 180 ha vineyard. In the coming weeks, he intends to present his technical and financial assistance plan to assist winemakers with this change in practices. The alternatives to herbicides retained are mainly mechanical but also vegetable. Robots, pressurized water or tea-based porridge could be used in the vineyards. At the cognac appellation level, two agri-environmental measures were recently included in the specifications to limit the use of chemical weed control, with the goal by 2025 of reducing the use of herbicides by 50%.
supersonico
26/4/2019
09:14
Shareholder revolt on ss and aa remuneration and the whole pay committee setup... tied in with share price appreciation and commercial success?? I would vote for that so this jam tomorrow story might bare fruit before they retire... grrrh it's beyond excessive their pay rises given the depreciating share price...
bjlk
26/4/2019
08:38
Different sort of 'emergency' I believe Monet. Use on Kiwi is More like a derogation as already approved Mevalone gets with Pomegranates. This is an 'emergency' cart as the 'urgent need' has come prior to the 'approval' paperwork horse in changing times.
supersonico
26/4/2019
08:24
Why didn't we get a RNS for this? 3LOGY: authorized for use in plant health emergency From 8 April it will be possible to use 3LOGY for Actinidia botrytis The botrytis ( Botrytis cinerea or gray mold), is a pathogen that causes severe changes in load of flowers, fruits, leaves and shoots of numerous crops The Botrytis on kiwifruit (or kiwi) manifests itself already in the early stages of flowering, growing in flowers with brownish rots that induce abundant drops and prevent normal fruit set. The fungus can also remain latent and subsequently cause serious damage to fruits that deteriorate to such an extent that they can no longer be sold. Botrytis develops especially in particularly wet years, Favored by heavy rains and repeated 3LOGY , innovative antibotritico based on terpenes, was authorized for a period of 120 days, from 8 April to August 5, for danger to plant health on botrytis Actinidia hTTp://www.sipcamitalia.it/it/news/12/3logy-autorizzato-l-impiego-per-emergenza-fitosanitaria/153_NC
monet
26/4/2019
08:16
It can be all summed up by Edenberg , NDA's , Incongruence, technical issues and Scandi Noir imo at the S curve mathematical collapse of the Green Revolution narrative. The 'Emergency' status tells those who follow the non 'effective' 'Direction of Travel news' everything we knew already and will be repeated across the board imo.
supersonico
26/4/2019
08:00
Surprising and welcome news today, which implies Cedroz is already highly rated and might even provide for an 'upgrade' from the broker! Early Cedroz sales in Italy will no doubt provide further food for thought in terms of the potential across 29 countries.
wan
26/4/2019
07:57
Today's RNS is a very positive news. Other EU states will follow.Imo the share price should open higher and who knows the week end press may pick up the Eden story....
hjs
26/4/2019
07:54
From today's RNS "Such "emergency" authorisations are allowed by EU member states when local regulatory authorities judge that they are needed in the local market in order to meet the requirements of growers in the absence of suitable commercially-available alternatives." Italy cannot be the only country that hasn't got "suitable commercially-available alternatives". I'd now expect more to follow "in short order" :). This seems like excellent and significant news to me. I'd also expect, based on the above statement, Cedroz to gain a very high market share and very quickly. Again, this will make a mockery of the recent Shore Capital report and allocated product shares, all of which of course, we are not meant to have visibility on!!!!!
investingisatrickygame
26/4/2019
07:23
Emergency Use due to limited alternatives ..News Italy grants "emergency use" authorisation for Cedroz to meet grower demands hTTps://www.investegate.co.uk/eden-research-plc--eden-/rns/italy-grants--emergency-use--cedroz-authorisation/201904260700101726X/ "The Italian market represents a significant opportunity for Cedroz and, as such, it is great to see the regulatory authorities respond positively by granting this emergency authorisation. This also verifies that there is a limited number of alternative products available to tackle nematodes in the Italian market and consequently growers need new tools to help control this damaging pest on a range of important high value crops."
supersonico
25/4/2019
23:21
Positive results or profits are the best PR's of any company. The next AGM is coming soon and my list of questions are being prepared...
sortudo7
25/4/2019
22:44
Brucie, I don't believe it would be "pumping up" the share price at all, but aligning it more closely to real value today, not future value. I simply do not believe that Eden is worth just £22 million. Based on how valuations are assessed, I believe 50p+ is not out of sync with where the business is today.
investingisatrickygame
25/4/2019
21:49
Investing, at risk of sounding boorish, I don't think there's any point in the bod here trying to pump up the share price, when the only think that will really drive this forward is delivery of news. We know what that means, and it's a waiting game. Unfortunately, two items should have arrived end of year 2018, as we know, and that in itself has affected credibility. Having said that, Lykele may wish to explain at the AGM why he has still not bought any shares.
brucie5
25/4/2019
20:53
I would have thought by now Investing you know the answer to that?
supersonico
25/4/2019
20:35
The only thing that really matters to you and me after all this time and the narrative delivered is the share price. One question for the BoD and everyone here. Do we really think Eden is fair value today at circa £22 million. If not, why not and what should it be? And assuming a higher value, what is Eden and their advisers going to do about it?
investingisatrickygame
Chat Pages: Latest  284  283  282  281  280  279  278  277  276  275  274  273  Older
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190627 12:09:23